Last updated September 12, 2026.
Plain-language disclosure: GLP.directory may receive a commission or fixed referral fee if you click a link marked “Partner link,” “Affiliate link,” or “Sponsored” and then complete a qualifying action. A qualifying action may be a consultation, enrollment, or purchase. This compensation supports the publication.
What compensation does not buy
Compensation does not increase a provider’s matcher score, determine an Access Award, remove material caveats, or guarantee favorable coverage. The matcher uses the preferences described in our methodology. Editorial staff should not know the payout when scoring a provider.
Where we disclose it
A disclosure appears close to a compensated recommendation or outbound action, where a reader is likely to notice it before clicking. Sponsored placements, if introduced, will be labeled “Sponsored” and separated from editorial rankings. A site-wide disclosure is additional context, not a substitute for a disclosure beside the relevant claim or link.
What a referral may cost you
A provider usually sets the consumer price. A commission may be included in its marketing cost. A discount or special offer may apply only when stated in the provider’s current terms. Compare the ordinary recurring total and cancellation terms directly before paying.
Current partnership research
| Brand | Public route | Status | What still needs verification |
|---|---|---|---|
| Direct Meds | Public application ↗ Terms ↗ | Application and public terms found | Rate and attribution window; terms limit use to approved creative/sites, bar PPC without approval, require FTC disclosure, and contain conflicting weekly/monthly payout language. |
| OrderlyMeds | Partner portal ↗ | Portal found | Current agreement, eligible products, payout event, reversals, attribution, PPC and trademark rules. |
| WeightWatchers | Impact application ↗ | $10 base per qualified subscription published | Whether Clinic/Med+ transactions—not only standard WW membership—are eligible under the Impact agreement. |
| Noom | Affiliate page ↗ | Route requires recheck | Whether Noom Med is eligible and which health claims or creatives require approval. |
| Hims & Hers | Affiliate page ↗ | Route requires recheck | Weight-loss eligibility, state/product limits, claim approval, trademarks, and reversals. |
| Ro Body | Partner inquiry ↗ | Public terms not confirmed | Publisher eligibility, destinations, commission event, product exclusions, and paid-media policy. |
| LifeMD | Direct outreach ↗ | Public terms not confirmed | Full publisher agreement and whether weight management is commissionable. |
| Found | Direct outreach ↗ | Public terms not confirmed | Program availability, allowed claims, eligible plans, term, attribution, and reversals. |
| Mochi Health | Provider contact ↗ | Publisher terms not confirmed | Do not substitute a member referral code for a signed publisher agreement. |
| IVIM Health | Provider contact ↗ | Public terms not confirmed | Publisher eligibility, approved content, payout, attribution, and restricted channels. |
| Henry Meds | Provider contact ↗ | Public terms not confirmed | Publisher contract and current eligibility of weight-management plans. |
| Eden | Provider contact ↗ | Public terms not confirmed | Legal merchant, health-claim rules, eligible treatments, payout, and reversals. |
| Fridays | Provider contact ↗ | Public terms not confirmed | Promotion wording, four-month renewals, eligible paths, attribution, and cancellation reversals. |
| Amble Health | Provider contact ↗ | Public terms not confirmed | Publisher agreement, approved disclosures and claims, destinations, and reversals. |
| Remedy Meds | Provider contact ↗ | Public terms not confirmed | Publisher agreement, product eligibility, payout event, and paid-media policy. |
| FuturHealth | Provider contact ↗ | Public terms not confirmed | Which plan and medication paths qualify and how refunds affect commission. |
| ShedRx | Provider contact ↗ | Public terms not confirmed | Publisher terms, treatment exclusions, claims approval, and tracking window. |
| PlushCare | Direct outreach ↗ | Public terms not confirmed | Whether weight-management appointments or memberships are eligible. |
| Sesame | Partnership inquiry ↗ | Public terms not confirmed | Publisher eligibility, eligible service lines, tracking, and medical-claim policy. |
| Form Health | Direct outreach ↗ | Public terms not confirmed | Whether consumer referrals are accepted and how insurance eligibility is treated. |
| Calibrate | Direct outreach ↗ | Public terms not confirmed | Eligible enrollment routes, program term, tracking, and reversal policy. |
| Levity | Provider contact ↗ | Public terms not confirmed | Publisher agreement, term/prepayment claims, commission event, and reversals. |
| Fella Health | Provider contact ↗ | Public terms not confirmed | Publisher agreement, product eligibility, creative approval, and channel restrictions. |
| ReflexMD | Provider contact ↗ | Public terms not confirmed | Publisher agreement, payout trigger, allowed claims, and attribution. |
| Zealthy | Provider contact ↗ | Public terms not confirmed | Which membership/treatment events qualify and how cancellations are reversed. |
| knownwell | Direct outreach ↗ | Public terms not confirmed | Whether patient referrals are compensated and the healthcare-law review required. |
| 9amHealth | Partnership inquiry ↗ | Public terms not confirmed | Consumer versus employer referral eligibility and applicable compliance terms. |
Last registry review: September 10, 2026. “Not confirmed” means no public publisher agreement was located in the initial source audit; it does not prove that no private or network-managed program exists.
Important distinction
An application page is not an agreement. A referral code is not automatically a publisher program. A proposed private rate is not a public fact. GLP.directory treats a program as active only after written terms, destinations, disclosure language, and tracking have been approved.
Questions about a commercial relationship can be sent to partners@glp.directory. The Federal Trade Commission publishes additional guidance on clear disclosure of material connections.